Terns Pharmaceuticals Inc (TERN) Reports TERN-501 Met Primary Endpoint and All Secondary Endpoints in Phase 2a DUET Trial streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ HepaTx, a preclinical-stage biotechnology company developing cell therapies for liver diseases, announced today that Mazen Noureddin, MD, MHSc,.
/PRNewswire/ The growing prevalence of fatty liver disease in the U.S. has led the American Association for the Study of Liver Diseases (AASLD) to call for.